• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉血运重建时间:中介分析研究方法。

Time of coronary revascularization: methodology of a mediation analysis study.

机构信息

School of Population and Public Health (Sobolev), University of British Columbia; Centre for Clinical Epidemiology and Evaluation (Kuramoto), Vancouver Coastal Health Research Institute, Vancouver, BC

School of Population and Public Health (Sobolev), University of British Columbia; Centre for Clinical Epidemiology and Evaluation (Kuramoto), Vancouver Coastal Health Research Institute, Vancouver, BC.

出版信息

CMAJ Open. 2022 Dec 13;10(4):E1052-E1058. doi: 10.9778/cmajo.20210183. Print 2022 Oct-Dec.

DOI:10.9778/cmajo.20210183
PMID:36735232
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9828946/
Abstract

BACKGROUND

The advantage of coronary artery bypass grafting (CABG) over percutaneous coronary intervention (PCI), established in trials, may not be generalizable to populations in which the method of treatment determines the time to treatment. We sought to describe the methodology of a population-based observational study for assessing how changes in time to treatment may affect the comparative effectiveness of these 2 methods of coronary revascularization.

METHODS

We propose a framework of causal mediation analysis to compare the outcomes of choosing CABG over PCI, if patients selected for either method waited the same amount of time had they undergone a PCI. We will include patients who underwent a first-time, nonurgent isolated CABG or single-session PCI for multivessel or left main coronary artery disease from January 2001 to December 2016, in British Columbia. We will use absolute risk difference as a measure of the total effect of choosing CABG over PCI and partition it into the direct effect of the treatment choice and the effect mediated by the treatment-specific timing.

INTERPRETATION

Understanding how time to treatment mediates the relation between method of revascularization and outcomes will have implications for treatment selection, resource allocation and planning benchmarks. Findings on the benefits and risks of performing PCI or CABG within a certain time will guide multidisciplinary teams in determining the appropriate revascularization method for individual patients.

摘要

背景

在临床试验中,冠状动脉旁路移植术(CABG)优于经皮冠状动脉介入治疗(PCI),但这种优势可能不适用于治疗方法决定治疗时间的人群。我们旨在描述一项基于人群的观察性研究的方法,以评估治疗时间的变化如何影响这两种冠状动脉血运重建方法的比较效果。

方法

我们提出了一个因果中介分析框架,以比较选择 CABG 而非 PCI 的结果,如果选择这两种方法的患者等待相同的时间,他们是否会接受 PCI。我们将纳入 2001 年 1 月至 2016 年 12 月不列颠哥伦比亚省首次接受非紧急孤立性 CABG 或多血管或左主干冠状动脉疾病单次 PCI 的患者。我们将使用绝对风险差异作为选择 CABG 而非 PCI 的总效果的衡量标准,并将其分为治疗选择的直接效果和治疗特异性时间介导的效果。

解释

了解治疗时间如何调节血运重建方法与结果之间的关系,将对治疗选择、资源分配和规划基准产生影响。关于在特定时间内进行 PCI 或 CABG 的益处和风险的发现,将指导多学科团队为个体患者确定适当的血运重建方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d99/9828946/6c799fa01706/cmajo.20210183f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d99/9828946/6c799fa01706/cmajo.20210183f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d99/9828946/6c799fa01706/cmajo.20210183f1.jpg

相似文献

1
Time of coronary revascularization: methodology of a mediation analysis study.冠状动脉血运重建时间:中介分析研究方法。
CMAJ Open. 2022 Dec 13;10(4):E1052-E1058. doi: 10.9778/cmajo.20210183. Print 2022 Oct-Dec.
2
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
3
Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左心室射血分数严重降低患者的长期预后
JAMA Cardiol. 2020 Jun 1;5(6):631-641. doi: 10.1001/jamacardio.2020.0239.
4
One-stop hybrid coronary revascularization versus coronary artery bypass grafting and percutaneous coronary intervention for the treatment of multivessel coronary artery disease: 3-year follow-up results from a single institution.一站式杂交冠状动脉血运重建与冠状动脉旁路移植术和经皮冠状动脉介入治疗多支冠状动脉疾病:来自单中心的 3 年随访结果。
J Am Coll Cardiol. 2013 Jun 25;61(25):2525-33. doi: 10.1016/j.jacc.2013.04.007. Epub 2013 Apr 23.
5
10-Year Outcomes of Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Artery Disease.左主干冠状动脉疾病中支架与冠状动脉旁路移植术的 10 年结果比较。
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2813-2822. doi: 10.1016/j.jacc.2018.09.012. Epub 2018 Sep 24.
6
Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.冠状动脉旁路移植术与经皮冠状动脉介入治疗对多支血管病变患者长期死亡率和发病率的影响:动脉搭桥和支架时代随机临床试验的荟萃分析。
JAMA Intern Med. 2014 Feb 1;174(2):223-30. doi: 10.1001/jamainternmed.2013.12844.
7
CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.冠状动脉搭桥术与经皮冠状动脉介入治疗:多支动脉搭桥术在长期预后方面具有更大益处。
J Am Coll Cardiol. 2015 Sep 29;66(13):1417-27. doi: 10.1016/j.jacc.2015.07.060.
8
Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.冠状动脉旁路移植术与经皮冠状动脉介入治疗在冠状动脉血运重建中的比较:一项系统评价。
JAMA. 2013 Nov 20;310(19):2086-95. doi: 10.1001/jama.2013.281718.
9
The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study:5 年随访:多血管病变糖尿病患者经皮冠状动脉介入治疗与冠状动脉旁路移植术血运重建的比较。
J Cardiovasc Med (Hagerstown). 2010 Jan;11(1):26-33. doi: 10.2459/JCM.0b013e328330ea32.
10
Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.对于被归类为经皮冠状动脉介入治疗推荐等级为II级和III级的患者,在接受传统冠状动脉搭桥术治疗左主干病变后的长期预后及比较。
Eur J Cardiothorac Surg. 2014 Mar;45(3):431-7. doi: 10.1093/ejcts/ezt429. Epub 2013 Aug 26.

本文引用的文献

1
Calculating the sample size required for developing a clinical prediction model.计算开发临床预测模型所需的样本量。
BMJ. 2020 Mar 18;368:m441. doi: 10.1136/bmj.m441.
2
Evidence synthesis for constructing directed acyclic graphs (ESC-DAGs): a novel and systematic method for building directed acyclic graphs.证据综合构建有向无环图(ESC-DAGs):一种构建有向无环图的新颖而系统的方法。
Int J Epidemiol. 2020 Feb 1;49(1):322-329. doi: 10.1093/ije/dyz150.
3
Coronary Bypass Versus Percutaneous Revascularization in Multivessel Coronary Artery Disease.
多支冠状动脉疾病中的冠状动脉旁路移植术与经皮血运重建术的比较。
Ann Thorac Surg. 2019 Aug;108(2):474-480. doi: 10.1016/j.athoracsur.2019.02.064. Epub 2019 May 2.
4
PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week.经皮冠状动脉介入治疗和冠状动脉旁路移植术治疗稳定性冠状动脉疾病:JACC 本周回顾主题。
J Am Coll Cardiol. 2019 Mar 5;73(8):964-976. doi: 10.1016/j.jacc.2018.11.053.
5
Mediation Analysis.中介分析
JAMA. 2019 Feb 19;321(7):697-698. doi: 10.1001/jama.2018.21973.
6
Considerations for the choice between coronary artery bypass grafting and percutaneous coronary intervention as revascularization strategies in major categories of patients with stable multivessel coronary artery disease: an accompanying article of the task force of the 2018 ESC/EACTS guidelines on myocardial revascularization.稳定型多支冠状动脉疾病主要类别患者选择冠状动脉旁路移植术和经皮冠状动脉介入治疗作为血运重建策略的考量:2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南工作组的附文
Eur Heart J. 2019 Jan 7;40(2):204-212. doi: 10.1093/eurheartj/ehy532.
7
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
8
Applied mediation analyses: a review and tutorial.应用中介分析:综述与教程
Epidemiol Health. 2017 Aug 6;39:e2017035. doi: 10.4178/epih.e2017035. eCollection 2017.
9
Adverse events while awaiting myocardial revascularization: a systematic review and meta-analysis.等待冠状动脉血运重建时的不良事件:系统评价和荟萃分析。
Eur J Cardiothorac Surg. 2017 Aug 1;52(2):206-217. doi: 10.1093/ejcts/ezx115.
10
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.美国心脏病学会/美国胸外科医师协会/美国心脏协会/美国超声心动图学会/美国核心脏病学会/心血管造影和介入学会/心血管计算机断层扫描学会/胸外科医师学会2017年稳定型缺血性心脏病患者冠状动脉血运重建适宜性标准:美国心脏病学会适宜性标准工作组、美国胸外科协会、美国心脏协会、美国超声心动图学会、美国核心脏病学会、心血管造影和介入学会、心血管计算机断层扫描学会及胸外科医师学会报告
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241. doi: 10.1016/j.jacc.2017.02.001. Epub 2017 Mar 10.